4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Nektar Therapeutics (NKTR) operates in the Biotechnology industry and is headquartered in San Francisco, United States with about 63 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, NKTR reported $55M in revenue and ($164M) in net income.
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally.
Interactive charts & full statements → Open the NKTR valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $55M | $98M | $90M | $92M | — |
| Gross Profit | $55M | $68M | $56M | $70M | — |
| Operating Income (EBIT) | ($131M) | ($130M) | ($135M) | ($240M) | — |
| Net Income | ($164M) | ($119M) | ($276M) | ($368M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $11M | $22M | $12M | $11M | $10M | — |
| Gross Profit | — | $22M | $12M | $11M | $10M | $21M |
| Operating Income (EBIT) | ($38M) | ($19M) | ($32M) | ($36M) | ($44M) | — |
| Net Income | ($45M) | ($36M) | ($36M) | ($42M) | ($51M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $280M | $304M | $398M | $711M | — |
| Total Liabilities | $191M | $243M | $267M | $344M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NKTR viewer.
About TickerBase · Data methodology & sources